candesartan cilexetil has been researched along with Parkinsonian Disorders in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Tian, YY | 1 |
| Shi, JP | 1 |
| Xie, W | 1 |
| Shi, JQ | 1 |
| Lu, J | 1 |
| Zhang, YD | 1 |
1 other study available for candesartan cilexetil and Parkinsonian Disorders
| Article | Year |
|---|---|
Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Dopaminergic N | 2013 |